| Primary |
| Epilepsy |
25.5% |
| Drug Use For Unknown Indication |
19.4% |
| Convulsion |
19.0% |
| Product Used For Unknown Indication |
17.1% |
| Grand Mal Convulsion |
2.3% |
| Convulsion Prophylaxis |
1.9% |
| Febrile Convulsion |
1.4% |
| Insomnia |
1.4% |
| Irritability |
1.4% |
| Overdose |
1.4% |
| Persecutory Delusion |
1.4% |
| Schizophrenia |
1.4% |
| Status Epilepticus |
1.4% |
| Depression |
0.9% |
| Nervous System Disorder |
0.9% |
| Post-traumatic Epilepsy |
0.9% |
| Psychotic Disorder |
0.9% |
| Alcohol Withdrawal Syndrome |
0.5% |
| Bladder Disorder |
0.5% |
| Cerebral Ischaemia |
0.5% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
16.4% |
| Completed Suicide |
13.1% |
| Stevens-johnson Syndrome |
9.8% |
| Fibromatosis |
6.6% |
| Convulsion |
4.9% |
| Corneal Opacity |
3.3% |
| Drug Eruption |
3.3% |
| Dupuytren's Contracture |
3.3% |
| Erythema Multiforme |
3.3% |
| Loss Of Consciousness |
3.3% |
| Medication Error |
3.3% |
| Overdose |
3.3% |
| Pneumonia Aspiration |
3.3% |
| Product Substitution Issue |
3.3% |
| Pyrexia |
3.3% |
| Screaming |
3.3% |
| Shock Haemorrhagic |
3.3% |
| Sleep Disorder |
3.3% |
| Somnolence |
3.3% |
| Status Epilepticus |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
24.2% |
| Epilepsy |
20.7% |
| Convulsion |
11.9% |
| Drug Use For Unknown Indication |
10.0% |
| Infantile Spasms |
4.0% |
| Status Epilepticus |
3.6% |
| Foetal Exposure During Pregnancy |
3.4% |
| Constipation |
2.6% |
| Depression |
2.4% |
| Schizophrenia |
2.3% |
| Infection |
2.0% |
| Convulsion Prophylaxis |
1.8% |
| Insomnia |
1.6% |
| Suicide Attempt |
1.5% |
| Pyrexia |
1.5% |
| Hypertension |
1.4% |
| Grand Mal Convulsion |
1.4% |
| Partial Seizures |
1.3% |
| Rheumatoid Arthritis |
1.2% |
| Wound Complication |
1.2% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
12.3% |
| Completed Suicide |
8.3% |
| Status Epilepticus |
8.0% |
| Stevens-johnson Syndrome |
6.8% |
| Rhabdomyolysis |
5.9% |
| Convulsion |
5.2% |
| Drug Ineffective |
5.2% |
| Somnolence |
4.9% |
| Respiratory Arrest |
4.6% |
| Suicide Attempt |
4.6% |
| Toxicity To Various Agents |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Overdose |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Drug Interaction |
3.4% |
| Maternal Exposure During Pregnancy |
3.4% |
| Poisoning |
3.4% |
| Grand Mal Convulsion |
3.1% |
| Weight Decreased |
2.8% |
| Drug Toxicity |
2.5% |
|
| Concomitant |
| Epilepsy |
26.9% |
| Drug Use For Unknown Indication |
15.4% |
| Convulsion |
15.0% |
| Product Used For Unknown Indication |
10.8% |
| Pain |
3.6% |
| Hypertension |
3.4% |
| Depression |
2.6% |
| Schizophrenia |
2.5% |
| Prophylaxis |
2.3% |
| Status Epilepticus |
1.8% |
| Constipation |
1.7% |
| Grand Mal Convulsion |
1.7% |
| Insomnia |
1.7% |
| Osteoporosis |
1.7% |
| Rheumatoid Arthritis |
1.6% |
| Convulsion Prophylaxis |
1.6% |
| Pneumonia |
1.5% |
| Hiv Infection |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Sedation |
1.4% |
|
| Convulsion |
9.4% |
| Weight Decreased |
9.0% |
| Vomiting |
8.5% |
| Status Epilepticus |
7.7% |
| Somnolence |
7.0% |
| Drug Ineffective |
5.9% |
| Death |
4.8% |
| Epilepsy |
4.8% |
| Rhabdomyolysis |
4.6% |
| Tremor |
4.6% |
| Pyrexia |
4.0% |
| Weight Increased |
3.9% |
| Pneumonia |
3.6% |
| Respiratory Failure |
3.6% |
| Urinary Tract Infection |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Liver Disorder |
2.9% |
| Nausea |
2.9% |
| Sepsis |
2.9% |
| Thrombocytopenia |
2.9% |
|
| Interacting |
| Epilepsy |
34.2% |
| Lennox-gastaut Syndrome |
12.3% |
| Product Used For Unknown Indication |
12.1% |
| Schizophrenia |
8.2% |
| Convulsion |
6.9% |
| Partial Seizures |
4.4% |
| Grand Mal Convulsion |
3.3% |
| Encephalitis |
3.1% |
| Constipation |
2.6% |
| Hiv Infection |
2.6% |
| Insomnia |
2.1% |
| Sedation |
1.3% |
| Back Pain |
1.0% |
| Pneumonia |
1.0% |
| Prophylaxis |
1.0% |
| Staphylococcal Sepsis |
1.0% |
| Diarrhoea |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Status Epilepticus |
0.8% |
| Acquired Immunodeficiency Syndrome |
0.5% |
|
| Drug Interaction |
30.1% |
| Status Epilepticus |
9.6% |
| Hallucination |
6.0% |
| Altered State Of Consciousness |
4.8% |
| Anticonvulsant Drug Level Decreased |
4.8% |
| Drug Level Decreased |
4.8% |
| Epilepsy |
4.8% |
| Tremor |
4.8% |
| Aphasia |
3.6% |
| Drug Toxicity |
3.6% |
| Fall |
3.6% |
| Transplant Rejection |
3.6% |
| Alanine Aminotransferase Increased |
2.4% |
| Anticonvulsant Drug Level Increased |
2.4% |
| Convulsion |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Intestinal Perforation |
2.4% |
| Anticonvulsant Drug Level Above Therapeutic |
1.2% |
| Anxiety |
1.2% |
| Arthritis Infective |
1.2% |
|
